tiprankstipranks
Advertisement
Advertisement

ATOS Stock Latest News

Atossa: Buy Rating Reiterated as DMD and Oncology Pipeline Advances; $20 Price Target Unchanged
RatingsAtossa: Buy Rating Reiterated as DMD and Oncology Pipeline Advances; $20 Price Target Unchanged
3d ago
ATOS
Jason McCarthy Reiterates Buy on Endoxifen Developer, Lifting 12-Month Price Target to $20 on Strong ER+ Breast Cancer Data and Pipeline Expansion
PremiumRatings
Jason McCarthy Reiterates Buy on Endoxifen Developer, Lifting 12-Month Price Target to $20 on Strong ER+ Breast Cancer Data and Pipeline Expansion
9d ago
ATOS
Atossa Therapeutics reports Q1 EPS ($1.11) vs. (78c) last year
PremiumThe Fly
Atossa Therapeutics reports Q1 EPS ($1.11) vs. (78c) last year
29d ago
ATOS
Atossa Therapeutics Shareholders Approve Proposals at 2026 Meeting
PremiumCompany Announcements
Atossa Therapeutics Shareholders Approve Proposals at 2026 Meeting
30d ago
8K
ATOS
Atossa Therapeutics’ Endoxifen shows breast cancer risk prevention in trial
PremiumThe Fly
Atossa Therapeutics’ Endoxifen shows breast cancer risk prevention in trial
1M ago
ATOS
Atossa Therapeutics says FDA grants RPD to (Z)-endoxifen to treat MAS
PremiumThe FlyAtossa Therapeutics says FDA grants RPD to (Z)-endoxifen to treat MAS
1M ago
ATOS
Atossa: Patent De‑Risking and Endoxifen Franchise Optionality Support Buy Rating and Upside to Target Price
Premium
Ratings
Atossa: Patent De‑Risking and Endoxifen Franchise Optionality Support Buy Rating and Upside to Target Price
2M ago
ATOS
Atossa Therapeutics Resolves Endoxifen Patent Disputes, Clarifies Rights
Premium
Company Announcements
Atossa Therapeutics Resolves Endoxifen Patent Disputes, Clarifies Rights
2M ago
8K
ATOS
Atossa Therapeutics target adjusted to $25 from $7 at H.C. Wainwright
PremiumThe Fly
Atossa Therapeutics target adjusted to $25 from $7 at H.C. Wainwright
2M ago
ATOS
Atossa Therapeutics reports 2025 EPS ($4.04), consensus ($3.91)
PremiumThe Fly
Atossa Therapeutics reports 2025 EPS ($4.04), consensus ($3.91)
2M ago
ATOS
Atossa Therapeutics announces addition of two biopharma executives to team
PremiumThe Fly
Atossa Therapeutics announces addition of two biopharma executives to team
3M ago
ATOS
VTI ETF Inflows Hold Steady Despite AI Sell-Off – 2/24/26
PremiumMarket News
VTI ETF Inflows Hold Steady Despite AI Sell-Off – 2/24/26
3M ago
L
CLB
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—2/23/26
PremiumMarket NewsVanguard Total Stock Market ETF (VTI) Daily Snapshot—2/23/26
3M ago
CLB
IMA
Atossa Therapeutics Launches New $50 Million ATM Program
Premium
Company Announcements
Atossa Therapeutics Launches New $50 Million ATM Program
4M ago
8K
ATOS
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—2/20/26
Premium
Market News
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—2/20/26
4M ago
L
CLB
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—2/19/26
PremiumMarket News
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—2/19/26
4M ago
L
CLB
Atossa Therapeutics Regains Nasdaq Compliance, Avoids Delisting Risk
PremiumCompany Announcements
Atossa Therapeutics Regains Nasdaq Compliance, Avoids Delisting Risk
4M ago
8K
ATOS
Atossa Therapeutics price target lowered to $10 from $35 at Craig-Hallum
PremiumThe Fly
Atossa Therapeutics price target lowered to $10 from $35 at Craig-Hallum
4M ago
ATOS
Atossa Therapeutics Issues 2026 Outlook and Strategic Update
PremiumCompany Announcements
Atossa Therapeutics Issues 2026 Outlook and Strategic Update
4M ago
8K
ATOS
Atossa Therapeutics: Strategic Endoxifen Opportunity in DMD and PRV Creates Buy-Rated Upside at Disconnected Valuation
PremiumRatingsAtossa Therapeutics: Strategic Endoxifen Opportunity in DMD and PRV Creates Buy-Rated Upside at Disconnected Valuation
4M ago
ATOS
Upcoming Stock Splits This Week (February 2 to February 6) – Stay Invested
Premium
Market News
Upcoming Stock Splits This Week (February 2 to February 6) – Stay Invested
4M ago
PBM
AREB
Atossa Genetics trading halted, news pending
Premium
The Fly
Atossa Genetics trading halted, news pending
4M ago
ATOS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >